Gemina Laboratories Ltd.
GLABF
$0.73
-$0.1894-20.60%
OTC PK
10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 29.90K | 149.70K | 1.20K | 700.00 | 2.10K |
Total Receivables | 10.30K | 23.60K | 28.50K | 28.80K | 139.50K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 79.80K | 100.30K | 44.30K | 39.80K | 57.30K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 119.90K | 273.60K | 74.00K | 69.30K | 198.80K |
|
|||||
Total Current Assets | 119.90K | 273.60K | 74.00K | 69.30K | 198.80K |
Net Property, Plant & Equipment | 248.20K | 90.80K | 249.10K | 276.00K | 296.70K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 1.10M | 1.08M | 1.05M | 1.09M | 1.21M |
|
|||||
Total Accounts Payable | 1.80M | 1.61M | 1.40M | 1.25M | 934.00K |
Total Accrued Expenses | 732.40K | 532.50K | 350.10K | 664.90K | 345.90K |
Short-term Debt | 831.70K | 808.30K | 728.10K | 149.50K | 144.00K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 69.50K | 25.10K | 58.70K | 59.30K | 55.40K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 51.70K |
Total Other Current Liabilities | -- | -- | -- | -- | 51.70K |
Total Current Liabilities | 3.44M | 2.98M | 2.53M | 2.12M | 1.53M |
|
|||||
Total Current Liabilities | 3.44M | 2.98M | 2.53M | 2.12M | 1.53M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 831.70K | 808.30K | 728.10K | 149.50K | 144.00K |
Capital Leases | 144.30K | 26.40K | 134.70K | 154.00K | 162.90K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.58M | 3.01M | 2.67M | 2.27M | 1.69M |
|
|||||
Common Stock & APIC | 8.67M | 8.72M | 8.18M | 8.40M | 8.09M |
Retained Earnings | -13.93M | -13.44M | -12.80M | -12.53M | -11.52M |
Treasury Stock & Other | 2.78M | 2.79M | 3.00M | 2.94M | 2.95M |
Total Common Equity | -2.48M | -1.92M | -1.62M | -1.18M | -482.50K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.48M | -1.92M | -1.62M | -1.18M | -482.50K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.48M | -1.92M | -1.62M | -1.18M | -482.50K |
|